Brief: Emergent Biosolutions Marks 10-Year Anniversary Of The U.S. FDA Approval Of Narcan® Nasal Spray And Reinforces Its Commitment To Increasing Naloxone Access

Emergent BioSolutions

18/11/2025 13:19

Emergent BioSolutions Inc EBS.N:

EMERGENT BIOSOLUTIONS MARKS 10-YEAR ANNIVERSARY OF THE U.S. FDA APPROVAL OF NARCAN® NASAL SPRAY AND REINFORCES ITS COMMITMENT TO INCREASING NALOXONE ACCESS

Source text: ID:nGNX90rqpS

Further company coverage: EBS.N